Skip to main content

Advertisement

SpringerLink
Log in

Circulating serum levels of angiopoietin-1 and angiopoietin-2 in nasopharynx and larynx carcinoma patients

  • Original Article
  • Published:
Tumor Biology

Abstract

We aimed to determine the serum levels of angiogenic factors, namely angiopoietins, in nasopharyngeal and laryngeal carcinoma patients. We also aimed to seek the relation of these molecules with tumor grade and their utility as diagnostic biomarkers. We evaluated angiopoietin 1 and 2 levels innasopharynx and larynx cancer patients before treatment. Angiopoietin 2 levels were significantly elevated in larynx carcinoma patients and tended to be elevated in nasopharynx cancer patients compared with healthy controls. However, angiopoietin 1 levels were similar in cancer patients and controls. Angiopoietin 1 levels were significantly higher in nasopharyngeal cancer patients with advanced stages compared to earlier stages. On the other hand, angiopoietin 2 levels were similar in advanced and earlier stage cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Carla C, Daris F, Cecilia B, Francesca B, Francesca C, Paolo F. Angiogenesis in head and neck cancer: a review of the literature. J Oncol. 2012;2012:358472.

    Article  PubMed  Google Scholar 

  2. Tas F, Duranyildiz D, Oguz H, Camlica H, Yasasever V, Topuz E. Circulating levels of vascular endothelial growth factor (VEGF), matrix metalloproteinase-3 (MMP-3), and BCL-2 in malignant melanoma. Med Oncol. 2008;25:431–6.

    Article  PubMed  Google Scholar 

  3. Demasi AP, Silva CA, Silva AD, Furuse C, Soares AB, Altemani A, et al. Expression of the vascular endothelial growth factor and angiopoietins in mucoepidermoid carcinoma of salivary gland. Head Neck Pathol. 2012;6:10–5.

    Article  PubMed  Google Scholar 

  4. Melen-Mucha G, Niedziela A, Mucha S, Motylewska E, Lawnicka H, Komorowski J, et al. Elevated peripheral blood plasma concentrations of tie-2 and angiopoietin 2 in patients with neuroendocrine tumors. Int J Mol Sci. 2012;13:1444–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Huang H, Bhat A, Woodnutt G, Lappe R. Targeting the ANGPT-TIE2 pathway in malignancy. Nat Rev Cancer. 2010;10:575–85.

    Article  CAS  PubMed  Google Scholar 

  6. Bessa V, Loukides S, Hillas G, Delimpoura V, Simoes D, Kontogianni K, et al. Levels of angiopoietins 1 and 2 in induced sputum supernatant in patients with COPD. Cytokine. 2012;58:455–60.

    Article  CAS  PubMed  Google Scholar 

  7. Gardizi M, Kurschat C, Riese A, Hahn M, Krieg T, Mauch C, et al. A decreased ratio between serum levels of the antagonistic angiopoietins 1 and 2 indicates tumour progression of malignant melanoma. Arch Dermatol Res. 2012;304:397–400.

    Article  CAS  PubMed  Google Scholar 

  8. Karatzanis AD, Koudounarakis E, Papadakis I, Velegrakis G. Molecular pathways of lymphangiogenesis and lymph node metastasis in head and neck cancer. Eur Arch Otorhinolaryngol. 2012;269:731–7.

    Article  CAS  PubMed  Google Scholar 

  9. Volkova E, Willis JA, Wells JE, Robinson BA, Dachs GU, Currie MJ. Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer. Br J Cancer. 2011;104:51–9.

    Article  CAS  PubMed  Google Scholar 

  10. Wieloch M, Swiatkowska M, Libiszewski M, Hedayati M, Drozda R, Kolomecki K. Assessment of the selected, late phase of angiogenesis factors’ concentration in colorectal cancer patients. Pol Merkur Lekarski. 2009;27:466–9.

    PubMed  Google Scholar 

  11. Sallinen H, Heikura T, Laidinen S, Kosma VM, Heinonen S, Yla-Herttuala S, et al. Preoperative angiopoietin-2 serum levels: a marker of malignant potential in ovarian neoplasms and poor prognosis in epithelial ovarian cancer. Int J Gynecol Cancer. 2010;20:1498–505.

    PubMed  Google Scholar 

  12. Yuan HT, Khankin EV, Karumanchi SA, Parikh SM. Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium. Mol Cell Biol. 2009;29:2011–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Hu B, Cheng SY. Angiopoietin-2: development of inhibitors for cancer therapy. Curr Oncol Rep. 2009;11:111–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ribatti D, Vacca A, Presta M. The discovery of angiogenic factors: a historical review. Gen Pharmacol. 2000;35:227–31.

    Article  CAS  PubMed  Google Scholar 

  15. Chien CY, Su CY, Chuang HC, Fang FM, Huang HY, Chen CM, et al. Angiopoietin-1 and -2 expression in recurrent squamous cell carcinoma of the oral cavity. J Surg Oncol. 2008;97:273–7.

    Article  PubMed  Google Scholar 

  16. Mitsutake N, Namba H, Takahara K, Ishigaki K, Ishigaki J, Ayabe H, et al. Tie-2 and angiopoietin-1 expression in human thyroid tumors. Thyroid. 2002;12:95–9.

    Article  CAS  PubMed  Google Scholar 

  17. Nagata J, Kijima H, Hatanaka H, Tokunaga T, Kamochi J, Abe Y, et al. Angiopoietin-1 and vascular endothelial growth factor expression in human esophageal cancer. Int J Mol Med. 2002;10:423–6.

    CAS  PubMed  Google Scholar 

  18. Xu G, Lou W, Sun Z, Zhang P. Expression of angiopoietin-1, 2 and its relationship with angiogenesis in laryngeal squamous cell carcinoma. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2008;22:772–6.

    PubMed  Google Scholar 

  19. Li C, Feng HC, Chen JC, Song YF. Expression and significance of angiopoietin-1 and angiopoietin-2 in oral squamous cell carcinoma. Ai Zheng. 2005;24:1388–93.

    CAS  PubMed  Google Scholar 

  20. Li C, Zhang B, Wang ZH, Chen JC, Li B, Wang SX, et al. Significance of a reversal expression of the angiopoietin-1 and 2 in oral squamous cell carcinoma. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009;44:412–8.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istanbul University Oncology Institute, Istanbul, Turkey

    Murat Emin Güveli, Derya Duranyildiz, Ahmet Karadeniz, Elif Bilgin, Murat Serilmez, Hilal Oguz Soydinc & Vildan Yasasever

Authors
  1. Murat Emin Güveli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Derya Duranyildiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ahmet Karadeniz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Elif Bilgin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Murat Serilmez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hilal Oguz Soydinc
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Vildan Yasasever
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Murat Emin Güveli or Derya Duranyildiz.

Ethics declarations

Conflicts of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Güveli, M.E., Duranyildiz, D., Karadeniz, A. et al. Circulating serum levels of angiopoietin-1 and angiopoietin-2 in nasopharynx and larynx carcinoma patients. Tumor Biol. 37, 8979–8983 (2016). https://doi.org/10.1007/s13277-015-4777-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-4777-0

Keywords

Search

Navigation